A collaborative study with Harvard Medical School
Accelerating Wound Healing in Chronic and Post-Surgical Wounds with 100% Chitosan and Bioactive Microfiber Gelling Technology (BMG): A Case Study
Publication Details:
Syafiqah, M.S., Hamizah, N., Hamishatul, S.A.M. & Shukur, A. (n.d.) Accelerating wound healing in chronic wound and post-surgical wound with 100% chitosan and bioactive microfiber gelling technology (BMG): A case studies.
Wound Details
Chronic Wound (Diabetic Foot Ulcer) located on the dorsum of the left foot
Key Findings and Data:
- Post-surgical wound: ~80% reduction in wound dimensions over 12 weeks
- Granulation and epithelialization improved to 95%
- Excellent exudate control, preventing maceration and maintaining peri-wound integrity
- Pain reduction: VAS scores reduced to 0 after 12 weeks
- No infection observed throughout the treatment period
Key Insights
- MaxioCel dressing provides optimal moisture balance while preventing wound maceration.
- Advanced fluid-locking ability ensures controlled exudate absorption, reducing dressing change frequency.
- Painless application and removal, improving patient compliance and comfort.
- MaxioCel supports faster wound healing by enhancing granulation and epithelialization, crucial for chronic and post-surgical wound recovery.
- MaxioCel’s antimicrobial and anti-inflammatory properties contribute to wound healing by reducing bacterial load and inflammation.
Related Publications
Evaluation of a 100% Chitosan Dressing in the Treatment of Diabetic Foot Ulcers
Chronic Wound Debridement in an Acute Setting
Severe Pressure Ulcer Debridement in the Acute Sector
A Multi-disciplinary Team Approach to the Management
